Evidence map›Paper›PMID 21844238›Full record

ArticleInfection and immunity2011

Proteomic analysis of Anaplasma phagocytophilum during infection of human myeloid cells identifies a protein that is pronouncedly upregulated on the infectious dense-cored cell.

Matthew J Troese, Amandeep Kahlon, Stephanie A Ragland, Andrew K Ottens, Nore Ojogun, Kristina T Nelson, Naomi J Walker, Dori L Borjesson, Jason A Carlyon

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. A Systematic Review on the Occurrence ofPathogens (Basel, Switzerland) · 2025
    Pooled it
  2. mBio · 2026
    Article
  3. Article
  4. Article
  5. Establishing the intracellular niche of obligate intracellular vacuolar pathogens.Frontiers in cellular and infection microbiology · 2023
    Review
  6. Article
  7. Article
  8. Epidemiological and Clinicopathological Features ofFrontiers in veterinary science · 2021
    Review
  9. Idiosyncratic Biogenesis of Intracellular Pathogens-Containing Vacuoles.Frontiers in cellular and infection microbiology · 2021
    Review
  10. Article
  11. Article
  12. Global Transcription Profiles ofFrontiers in veterinary science · 2020
    Article
  13. Article
  14. Review
  15. Detection and Phylogenetic Characterization ofFrontiers in cellular and infection microbiology · 2018
    Article
  16. Article
  17. Article
  18. Frontiers in cellular and infection microbiology · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Matthew J TroeseDepartment of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, P.O. Box 980678, Richmond, VA 23298-0678, USA.
Amandeep Kahlon
Stephanie A Ragland
Andrew K Ottens
Nore Ojogun
Kristina T Nelson
Naomi J Walker
Dori L Borjesson
Jason A Carlyon
Virginia Commonwealth University · USUniversity of California, Davis · US

Funding

The roles of Anaplasma phagocytophilum surface proteins in infectionR01AI072683 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CARLYON, JASON A · 2007 to 2021
$5.8M
The roles of Anaplasma phagocytophilum surface proteins in infectionR37AI072683 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI Jason A Carlyon · 2022 to 2026
$2.6M
Pathobiological roles of Anaplasma phagocytophilum inclusion membrane proteinsR21AI090170 · NIAID · VIRGINIA COMMONWEALTH UNIVERSITY · PI CARLYON, JASON A · 2010 to 2011
$409k
NIAID NIH HHS R01 AI072683NIAID NIH HHS R01 AI072683-04S1NIAID NIH HHS R21 AI090170NIAID NIH HHS R37 AI072683
6 · The paper itself

Abstract

Anaplasma phagocytophilum is an obligate intracellular bacterium that invades neutrophils to cause the emerging infectious disease human granulocytic anaplasmosis. A. phagocytophilum undergoes a biphasic developmental cycle, transitioning between an infectious dense-cored cell (DC) and a noninfectious reticulate cell (RC). To gain insights into the organism's biology and pathogenesis during human myeloid cell infection, we conducted proteomic analyses on A. phagocytophilum organisms purified from HL-60 cells. A total of 324 proteins were unambiguously identified, thereby verifying 23.7% of the predicted A. phagocytophilum proteome. Fifty-three identified proteins had been previously annotated as hypothetical or conserved hypothetical. The second most abundant gene product, after the well-studied major surface protein 2 (P44), was the hitherto hypothetical protein APH_1235. APH_1235 homologs are found in other Anaplasma and Ehrlichia species but not in other bacteria. The aph_1235 RNA level is increased 70-fold in the DC form relative to that in the RC form. Transcriptional upregulation of and our ability to detect APH_1235 correlate with RC to DC transition, DC exit from host cells, and subsequent DC binding and entry during the next round of infection. Immunoelectron microscopy pronouncedly detects APH_1235 on DC organisms, while detection on RC bacteria minimally, at best, exceeds background. This work represents an extensive study of the A. phagocytophilum proteome, discerns the complement of proteins that is generated during survival within human myeloid cells, and identifies APH_1235 as the first known protein that is pronouncedly upregulated on the infectious DC form.

Indexed as

Gene Expression ProfilingAmino Acid SequenceAnaplasma phagocytophilumBacterial ProteinsCentrifugation, Density GradientChromatography, LiquidEhrlichiaGene Expression Regulation, BacterialHL-60 CellsHumansMolecular Sequence AnnotationMyeloid CellsProteomicsSpecies SpecificityTandem Mass SpectrometryUp-RegulationBacterial Proteins

Identifiers

PMID21844238
PMCPMC3257945
OpenAlexW2144647412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.